Doxorubicin and C-13 Deoxydoxorubicin Effects on Ryanodine Receptor Gene Expression
Authors:
- Briant E. BurkeBBBriant E. Burke
- Barry J. CusackBCBarry J. Cusack
- Gerald M. WalshGWGerald M. Walsh
- Yumei L. ZhangYZYumei L. Zhang
- Philip S. MushlinPMPhilip S. Mushlin
- Richard D. OlsonRORichard D. Olson
- 1 March 2002
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 291 (3) , 433-438
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Sarcoplasmic Reticulum Calcium Release Is Stimulated and Inhibited by Daunorubicin and DaunorubicinolToxicology and Applied Pharmacology, 2000
- Daunorubicin cardiotoxicityBiochemical Pharmacology, 2000
- Molecular Basis of Anthracycline-Induced Cardiotoxicity and Its PreventionMolecular Genetics and Metabolism, 2000
- The Exogenous NADH Dehydrogenase of Heart Mitochondria Is the Key Enzyme Responsible for Selective Cardiotoxicity of AnthracyclinesZeitschrift für Naturforschung C, 1998
- Contractile Failure in Chronic Doxorubicin-induced CardiomyopathyJournal of Molecular and Cellular Cardiology, 1997
- Anthracycline-Induced CardiotoxicityAnnals of Internal Medicine, 1996
- Dose-dependent Increase in Sensitivity to Calcium-induced Mitochondrial Dysfunction and Cardiomyocyte Cell Injury by DoxorubicinJournal of Molecular and Cellular Cardiology, 1996
- Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model.Journal of Clinical Investigation, 1993
- Anthracycline-induced Tension in Permeabilized Cardiac Fibers: Evidence for the Activation of the Calcium Release Channel of Sarcoplasmic ReticulumJournal of Molecular and Cellular Cardiology, 1993
- Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in ChildhoodNew England Journal of Medicine, 1991